BACKGROUND: Regulatory T cells (T regs ) are key players in immune tolerance. They express the transcription factor FOXP3 and are dependent of the STAT5 signaling for their homeostasis. So far, the study of phosphorylated epitopes by flow cytometry
www.impactjournals.com/oncotarget naive T convs by TCR stimulation along with TGF-β, IL-10 or retinoic acid signaling (induced T regs ) [6] . In addition to distinctions based on their origin, T reg can be further subdivided into central or naive T regs ( [4, [7] [8] [9] . Importantly, in humans, effector T regs can be further separated between activated (HLA-DR + ) effector T regs that are highly proliferating, and HLA-DR neg effector T regs that are less proliferating [9] .
In the last decade, animal studies have evidenced that restoring the T-cell balance in favor of T regs allowed the control of autoimmunity in several animal models of rheumatologic diseases [10] . Further, T reg administration prevented graft-versus-host disease (GVHD, a redoubtable complication of allogeneic hematopoietic cell transplantation caused by donor immune cells contained in the graft reacting against recipient healthy tissues [11] ) both in mouse to mouse and in humanized mouse models of GVHD [12] [13] [14] [15] . Further, T reg infusion also prolonged human skin graft survival in humanized mice [16] .
These observations in animal models prompted the initiation of pilot clinical studies of T reg infusion as prevention or treatment of GVHD [17] [18] [19] , or as prevention of solid organ rejection [20] .
IL-2 is a member of the common cytokine gamma chain family that plays a central role in T reg homeostasis through stimulation of the STAT5 pathway [4, 21] . This prompted Koreth et al. to investigate the safety and efficacy of low-dose IL-2 administration (with the aim of boosting T regs ) in patients with chronic GVHD [22] . The authors observed that administration of lowdose IL-2 not only successfully increased T reg blood counts but also induced clinical responses in half of the patients. Administration of low-dose IL-2 resulted also in increased T reg counts and clinical responses in patients with autoimmune diseases such as hepatitis C virusinduced vasculitis [23] or type 1 diabetes [24] . With the development of such cytokine-based immunotherapies, monitoring of the phosphorylation level of key players in target signaling pathways (and particularly of STAT5), simultaneously in several cell sub-populations, is of great interest in order to assess treatment efficacy early.
So far, the study of phosphorylated epitopes by flow cytometry required treating the cells with methanol, which is harmful for many extra-and intra-cellular epitopes and compromises multiparameter analyses. Recently, a new reagent kit, the PerFix EXPOSE kit (Beckman Coulter), was designed to allow studying phosphorylated epitopes without compromising other epitopes. In the present report, we compared this new procedure with reference permeabilization protocols for (non)-phosphorylated epitopes to validate it and used it to study T reg subsets response to IL-2 in human and mouse samples. Our results showed that the PerFix technique is suitable for combined phospho STAT5 monitoring and accurate immunophenotyping in human and mouse samples. We also highlighted differential responses to IL-2 among T reg subsets.
rEsULts AND DIscUssION
Validation of a multicolor staining to monitor phospho stAt5 levels in human t reg subsets
To assess the capacity of the PFE kit to allow the accurate quantification of phospho STAT5 in combination with surface (CD4, CD25, CD127, HLA-DR and CD45RA) and non-phosphorylated intracellular (FOXP3, KI67) epitopes, we compared this procedure with the conventional permeabilization method for phosphoepitopes (Methanol (MeOH)-based method) and the conventional permeabilization procedure for FOXP3 and KI67 staining (Paraformaldehyde (PFA) -based method). In order to assess the impact of any permeabilization treatment on the expression of surface epitopes, cells were also analyzed after staining of surface epitopes without any further permeabilization. These comparisons were repeated twice with 8 healthy volunteers and similar results were found in each experiment. Results from the first experiment are presented hereafter as representative example. The following combination of antibodies was used: CD4-PE-Cy5, CD25-BV421, CD127-biotinestrepatavidine-PE-Cy7, CD45RA-BV510, HLA-DR-APC-efluor780, FOXP3-AlexaFluor488, KI67-PE and phospho STAT5-AlexaFluor647 (detailed in materials and methods).
Using the gating strategy described in Figure 1A , we observed similar frequencies of CD4 Next we compared FOXP3 + frequency within the CD25 high CD127 low population and observed comparable FOXP3 + frequency among cells permeabilized with the PFA or with the PFE method, highlighting the successful and accurate staining of FOXP3 with this later procedure ( Figure 1E ). In contrast, there was a trend for decreased FOXP3 + frequency within the CD4 + CD25 high CD127 low population in cells permeabilized with the MeOH procedure. Regarding KI67 staining, no significant difference of frequency within either T reg or T conv populations was found between the three permeabilization protocols ( Figure 1F ). Importantly, similar proportions of naive and activated effector T regs were observed with the PFA and PFE procedures ( Figure 1G-1H ). In contrast, the methanol permeabilization procedure strikingly decreased the frequency of naive T regs , highlighting the deleterious impact of this permeabilization technique on certain surface epitopes such as CD45RA, although we can not exclude that by trying several CD45RA epitopes satisfying results could have been be achieved also with the methanol technique.
Next, we compared STAT5 phosphorylation levels (evaluated as mean fluorescence intensity (MFI) of phospho STAT5-APC) in T regs , normalized on T conv phospho STAT5 levels to reduce inter-assay variability of MFI between PFE and methanol permeabilization methods, after stimulation with 10 IU/ml of IL-2. Importantly, no difference between the two methods was observed ( Figure  1I ), demonstrating the reliability of the PFE technique for phospho STAT5 analysis. This experiment further evidenced higher levels of phospho STAT5 in T regs than in T convs following stimulation with low-dose IL-2, as recently observed by another group of investigators [24] .
Finally, we assessed the variability for each donor between the PFE and reference technique (PFA or MeOH Altogether these data validate an 8-color staining method allowing measurement of phospho STAT5 levels in human T reg subsets.
In human PbMcs, activated effector t regs have higher phospho stAt5 levels than other t reg subsets after stimulation with IL-2
Despite the growing knowledge on human T regs , little is known about the homeostatic properties of their sub-populations. Therefore, we took advantage of the PFE kit to study the respective capacities of the different T reg subsets at phosphorylating STAT5 in response to IL-2.
First we performed this comparison with low-dose (10 IU/ml) IL-2. The highest phospho STAT5 levels were found in activated effector T regs , followed by HLA-DR neg effector T regs , while naive T regs had the lowest levels of phospho STAT5 ( Figure 2A ). We then examined whether phospho STAT5 levels correlated with CD25 expression by T regs . We first observed that, as seen with phospho STAT5 levels, activated effector T regs had the highest expression of CD25, followed by HLA-DR neg effector T reg and naive T reg ( Figure 2B ). These data are in concordance with those reported by Miyara et al. showing higher CD25 expression in activated effector T regs than in naive T regs [8] . Further, taking data from T conv and T reg subsets together, there was a strong correlation between phospho STAT5 and CD25 levels (Spearman r = 0.86, p < 0.0001, Figure 2C ). These findings demonstrate that the different T reg subsets are not homogeneous in terms of response to IL-2 stimulation.
In order to verify that these observations remained present in basal conditions, we performed the same analyses with unstimulated T regs and observed significantly higher phospho STAT5 levels in activated effector T regs than in the two other T reg subpopulations, while no differences were detected between HLA-DR neg effector T regs and naive T regs ( Figure 2D ).
To further evaluate the response of the various T reg subsets to IL-2, we compared phospho STAT5 levels in the three T reg subsets after stimulation with an 8-log range of IL-2 concentration ( Figure 2E and Supplemental Figure 2 ). As observed above, activated effector T regs had the highest phospho STAT5 levels, followed by HLA-DR neg effector T regs and naive T regs . Specifically, the log half maximal effective concentration (log(EC 50 )) of activated effector T regs (-0.165) was lower than the log(EC 50 ) of HLA-DR neg effector T regs (0.096, p = 0.0495) and naive T regs (0.039, p = 0.0768) subsets, supporting a higher proliferative capacity of this T reg subset over the two others. These results are consistent with the differences observed in unstimualted T regs and further demonstrate the heterogeneity of T reg subsets in terms of response to IL-2 stimulation. In addition, our observations are in line with a recent study reporting that high-dose IL-2 therapy in melanoma patients promoted a T reg subset with an activated phenotype [25] . Interestingly, we observed that the activated effector T regs had the highest suppressive activity in vitro, while the two other populations presented similar (lower) suppressive activities ( Figure 2F ). These + cell frequency A. as well as on phospho STAT5 levels in T regs b. was assessed by flow cytometry using the PFE technique for permeabilization. Data show median values of 9 replicates (3 biological replicates in triplicates / condition) with interquartile range (* p < 0.05, **p < 0.005, ***p < 0.0005). (C-D) NSG mice received 2.5 Gy total body irradiation and were injected with 5x10 6 human PBMC i.v. 24h later (day 0). They were injected with either PBS (daily from day 4 to 6), 15 mg/kg of cyclosporin A (CSA, daily from day 4 to 6), 10 mg/kg of ATG (day 6) or 50.000 IU of IL-2 (24h, 12h and 1h before sacrifice). At day 7, animals were sacrificed and spleens were collected for flow cytometry comparison of CD4 
Finally, we compared KI67 expression between T reg subsets and found the highest frequency of KI67 + cells within the activated effector T reg fraction, while the HLA-DR neg effector T regs had a higher KI67 expression than naive T regs ( Figure 2G ), in agreement with previous findings [9] . Given the pivotal function of STAT5 phosphorylation in T reg proliferation, a significant correlation was found between KI67 expression of T reg subsets and their level of phospho STAT5 after low-dose IL-2 stimulation (Spearman r = 0.82, p < 0.0001, Figure 2H ).
Because cryopreserved rather than fresh PBMCs are frequently used in clinical trials, we assessed phospho STAT5 levels in T reg subsets recovered from human cryopreserved PBMCs. As observed with freshly isolated PBMCs, activated effector T regs from cryopreserved PBMCs presented the highest levels of phospho STAT5, CD25 and KI67 in comparison with the two other subsets, while effector T regs had significantly higher levels of these markers than naive T regs (Supplemental Figure 3) . These data indicate that the PFE technique is reliable also for thawed PBMC samples.
Altogether these data suggest that the different proliferative capacities of T reg subsets may be dependent upon their divergent capacities to respond to IL-2 through the STAT5 pathway.
Impact of anti-thymocyte globulin (AtG) and cyclosporin A on t reg phospho stAt5 levels
Immunosuppressive drugs, such as anti-thymocyte globulin (ATG) and cyclosporin A (CSA) are widely used to prevent or treat pathologies where T convs and T regs play a critical role such as GVHD [26] . To gain further insight on the impact of these drugs on T regs , we assessed their impact on phospho STAT5 levels using the PFE technique. We first assessed this impact in vitro and observed that ATG dramatically increased the frequency of CD4 + CD25 high FOXP3 + T regs (as observed previously by other investigators [27, 28] ), while T reg frequency was reduced by CSA ( Figure 3A) . Interestingly, both ATG and CSA significantly reduced phospho STAT5 levels in T regs ( Figure 3B ). This suggests that T reg expansion by ATG is independent of STAT5 signaling and is rather the result of the conversion of T convs into T regs , as previously showed by other investigators [27] . In addition, the lowered levels of phospho STAT5 by CSA are probably the results of its inhibitory effect on IL-2 production.
We next investigated the impact of these compounds in vivo in NSG mice transplanted with human PBMCs. We observed that, in agreement with in vitro experiments, ATG dramatically increased T reg frequency, while the opposite was observed with CSA ( Figure 3C ). Further, while IL-2 significantly increased phospho STAT5 levels in T regs , the opposite was observed with ATG and CSA ( Figure 3D ).
Validation of a multicolor staining to monitor phospho stAt5 levels in mouse t reg
We next assessed the capacity of the PFE kit to allow the accurate quantification of phospho STAT5 levels in combination with surface (CD3, CD4, CD8, CD25) and non-phosphorylated intracellular (FOXP3 and Ki67) epitopes in murine splenocytes from 5 B10.D2 and 5 B10.BR mice ( Figure 4A ). The following combination of antibodies was used: CD3-V500, CD4-eFluor450, CD8-PE-Cy7, CD25-PerCP-Cy5.5, FoxP3-PE, Ki67-FITC and phospho STAT5-AlexaFluor647 (detailed in material and methods).
In slight contrast to what was observed with human PBMCs, the PFE kit slightly reduced the expression (MFI) of both CD25 and FoxP3 by T regs , while no impact was observed on CD3, CD4 and CD8 staining ( Figure  4B ). However, importantly, the frequencies of CD3 Next, we compared the T reg /T conv ratio of phospho STAT5 levels between PFE and methanol-based permeabilization and found no significant differences ( Figure 4E) .
Finally, we investigated whether the alteration of CD25 and FoxP3 staining with PFE could be reproduced with different antibodies than CD25-PerCP-Cy5.5 and FoxP3-PE that were used here above. As shown in Supplemental Figure 4 , CD25-PE showed satisfactory staining in comparison to the PFA condition while FoxP3-APC staining was completely lost. These results demonstrate that, for optimal results, the deleterious impact of PFE on specific antibodies should be evaluated before performing any analysis.
Altogether these data validate a 7-color staining method allowing measurement of phospho STAT5 levels together with Ki67 expression in mouse T-cell samples.
In mouse splenocytes, naive t regs have higher phospho stAt5 levels than effector t regs after stimulation with IL-2
Because IL-2 and phospho STAT5 play a major role in mouse T reg homeostasis [29] , we compared the phospho STAT5 response curve of naive and effector mouse T regs to various concentrations of IL-2 ( Figure 5A ) by using the following antibodies: CD4-eFluor450, CD25-PE-Cy7, CD62L-APC-eFluor780, CD44-FITC, CD103-BV510, FoxP3-PE, Ki67-PerCP-Cy5.5 and phospho STAT5-AlexaFluor647 (detailed in material and methods). In contrast to what was observed in human T regs , murine naive T regs responded to lower concentrations of IL-2 than effector T reg ( Figure 5B ). This is illustrated by the significant difference of log(EC 50 ) between the two subsets (naive T regs : subsets and found that naive T regs expressed higher levels of CD25 than effector T regs , in agreement with their response curves to IL-2 ( Figure 5C ) and with recently reported data [31] . As observed in human samples and taking data from T conv and T reg subsets together, there was a strong correlation between phospho STAT5 and CD25 levels (Spearman r = 0.82, p < 0.0001, Figure 5D ). However we found that activated T regs expressed dramatically higher levels of Ki67 than naive T reg ( Figure 5E ) and an inverse correlation between phospho STAT5 level and Ki67 was observed when taking data from T reg subsets together (Spearman r = -0.75, p < 0.0001, Figure 5F ). Because the time of exposure to IL-2 in our experiments (15 min) is insufficient to induce Ki67 expression through the phospho STAT5 pathway (similar frequencies of Ki67 were found between stimulated and unstimulated T regs , data not showed), these data suggest that T reg proliferation is conditioned by their activation status while their capacity to respond to IL-2 is conditioned by their expression of CD25.
In summary, we have validated a multicolor staining method that allows the measurement of STAT5 phosphorylation levels in human and murine T reg subsets. Further, comparison of phospho STAT5 levels in response to IL-2 between the different T reg subsets highlighted a striking divergence between the two species. These observations are in line with recent reports showing higher CD25 expression in activated effector T regs than in naive T regs in human PMBCs [8] , but higher CD25 expression in naive T regs than in effector T regs in mouse splenocytes [31] . Further, as IL-2 administration has been previously shown to increase naive T reg frequency in mouse [31] and activated ICOS + T reg in humans [25] , our work suggest that ex vivo response curves to cytokines might be predictive of the impact of specific cytokine administration on the homeostasis T regs and other T-cell population.
MAtErIALs AND MEtHODs

Volunteers
Blood from healthy adult volunteers (aged 21 to 37 years) was collected following written informed consent (approved by our local Ethic Committee). Peripheral blood mononuclear cells (PBMCs) were immediately isolated by density gradient centrifugation (Ficoll-Paque TM , GE Healthcare, Upsala, Sweden) and then resuspended in staining buffer PBS+3%FBS (Lonza, Verviers, Belgium) at a concentration of 1x10 6 /ml.
Animal experiments
For the study assessing the impact of immunosuppressive drugs on human cells in vivo, NODscid IL-2Rγ null (NSG) (The Jackson laboratory, Bar Harbor, ME) mice, aged from 8 to 9 weeks, were irradiated (2.5 Gy total body irradiation) and transplanted i.v. 24h later with 5x10 6 human PBMCs (freshly isolated from one healthy volunteer). Animal weight and survival were monitored daily, in agreement with the recommendation of our ethical committee. Mice were then injected intraperitoneally with either PBS daily on days 4, 5 and 6 post-transplantation, 15 mg/kg of cyclosporin A (CSA, Sandimmune, Novartis, Basel, Switzerland) daily on days 4, 5 and 6 post-transplantation, 10 mg/kg of ATG (ATGFresenius, Neovii Biotech GmbH, Gräfelfing, Germany) on day 6 post-transplantation, or 50.000 IU of IL-2 (Proleukin, Novartis), 25h, 15h and 1h before the sacrifice at day 7.
For murine T reg and phospho STAT5 analyses, mice of either the B10.BR or B10.D2 strains (aged from 8-10 weeks) were sacrificed according to the local ethics policies without receiving any particular treatment. Spleens of either NSG, B10.BR or B10.D2 mice were collected in RPMI supplemented with 5% FBS and were prepared to a single cell suspension. Cells were washed twice in staining buffer, filtered through a 75 µm nylon mesh to remove aggregates, and were resuspended at a concentration of 1x10 6 cells/ml in staining buffer.
cell culture and suppression assays
For in vitro drugs assays, freshly isolated human PBMCs from 3 healthy volunteers were activated in triplicate in the presence of anti-CD3/CD28 beads (BeadCell ratio 1:1, Invitrogen, Waltham, MA) in complete medium that consisted of RPMI 1640 L-glutamine (2mM) (Lonza) supplemented with penicillin (100 IU/ ml) (Lonza), streptomycin (10 mg/ml) (Lonza) and 10% human AB serum (Sigma-Aldrich, St. Louis, MO). Culture medium was supplemented with either PBS, 500 ng/ml of CSA, or 100 µg/ml of ATG Fresenius/Neovii. Cells were collected for flow cytometry analysis after 24h of incubation at 37°C, 5% CO 2 .
For suppression assays, T reg subsets were isolated from human PBMCs by flow cytometry (FACS Aria III, Becton Dickinson (BD), Bedford, MA). Sorted naive T convs were loaded with CFSE 5 µM (Invitrogen) and used as responder cells. Assays were performed in complete medium in the presence of anti-CD3/CD28 beads (BeadCell ratio 1:8, Invitrogen). Sorted T regs and responder cells were cultured in mixed lymphocyte reactions at different T reg :T resp ratios for 72h before analysis by flow cytometry.
IL-2 stimulation
Human PBMCs or murine splenocytes (1x10 6 cells/ml in staining buffer) were stimulated with human recombinant IL-2 (Peprotech EC ltd., London, UK) because recombinant human IL-2 has been proven to be also efficient in mouse [32, 33] . For all experiments other than dose-response curves, a concentration of 10 IU/ml was used, while for dose-response curve experiments, an 8-log range of concentrations was used for human and a 9-log range was used for murine experiments. Samples were stimulated for 15 min at 37°C and were immediately washed twice with staining buffer before processing for flow cytometry staining. This time of exposure was chosen based on phospho STAT5 levels observed in lymphocytes after different times of stimulation with 10 IU/ml (Supplemental Figure 5) , 15 min corresponding to a time point of maximal response.
Flow cytometry
The following antibodies specific for human epitopes were used: CD4-PE-Cy5 (RPA-T4), CD25-BV421 (M-A251, BD), CD127-biotin (eBioRDR5), CD45RA-BV510 (HI100, BD), HLA-DR-APC-efluor780 (LN3), FOXP3-AlexaFluor488 (259D, Biolegend, ImTech Antwerp, Belgium), posphoSTAT5-AlexaFluor647 (p7694, BD), Ki67-FITC (B56, BD), KI67-PerCP-Cy5.5 (B56, BD), KI67-PE (B56, BD) and anti-streptavidin-PE-Cy7. The following antibodies specific for mouse epitopes were used: CD3-V500 (500A2, BD), CD4-eFluor450 (RM4-5), CD8-PE-Cy7 (53-6.7), CD25-PerCP-Cy5.5 (PC61.5), CD25-PE-Cy7 (PC61, BD), CD25-PE (PC61.5), CD103-BV510 (M290, BD), CD44-FITC (IM7), CD62L-APC-eFluor780 (MEL-14), FoxP3-APC (FJK-16s), and FoxP3-PE (FJK-16s) (all from eBioscience, unless indicated otherwise). Cells (1x10 20 min at 4°C in the dark and washed with staining buffer. This process was repeated for a 15-minute period for the streptavidin staining step. Then, samples were either not permeabilized and kept in PBS at 4°C until analysis by flow cytometry (Non Permeabilized (NP) condition) or were permeabilized by the use of one of three different procedures: the paraformaldehyde (PFA)-based method with FOXP3 Staining Buffer Set (eBioscience); the methanol (MeOH)-based method with Lyse/Fix buffer (Becton Dickinson) followed by Phosflow Perm Buffer III (Becton Dickinson) (Methanol-based method) or the PerFix EXPOSE (PFE, Beckman Coulter, Brea, CA) method. Manufacturer instructions were followed for each procedure. Data were acquired on a FACS Canto II (Becton Dickinson) and were analyzed with FlowJo v7.6.5 (Treestar Inc., San Carlos, CA). 
Gating strategy and definition of T reg subsets
CD103
+ lymphocytes [4] .
statistical analyses
The Mann-Whitney U test was used to compare flow cytometry data from different treatments. The extra sumof-squares F test was used to compare the half maximal effective concentrations (EC 50 ). The Spearman test was used to assess correlations. Statistical analyses were carried out with Graphpad Prism 5.0 (Graphpad Software, San Diego, CA). P values < 0.05 were considered as statistically significant.
